Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study

Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study

ObjectiveCurrent guidelines recommend potent P2Y12 inhibitors such as ticagrelor over clopidogrel as part of the dual antiplatelet therapy (DAPT) after ST-segment elevation myocardial infarction (STEMI), irrespective of final management strategy. The aim of this multicenter prospective cohort study...

Full description

Bibliographic Details
Main Authors: Xiao-Fan Yu, Hong-Wu Chen, Jie Xu, Qi-Zhi Xu, Xiao-Hong Zhang, Bin-Bin Li, Bang-Long Xu, Li-Kun Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
bivalirudin
heparin
ticagrelor
ST-segment elevation myocardial infarction
primary percutaneous coronary intervention
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.932054/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.932054/full

Similar Items